Johnson & Johnson’s Q3 Profit and Revenue Beat View; Forecast In-Line with Estimates (JNJ)

Share |

Diversified healthcare giant Johnson & Johnson ( JNJ ) on Tuesday posted better-than-expected third quarter earnings results and offered an in-line full-year forecast.

The New Brunswick, NJ-based company reported third quarter net income of $3 billion, or $1.05 per share, compared with $3.2 billion, or $1.15 per share, in the year-ago period. Excluding special items, adjusted profit was $1.25 per share.

Revenue rose 6.5% from last year to $17.05 billion.

On average, Wall Street analysts expected a smaller profit of $1.21 per share, on lower revenue of $17 billion.

Looking ahead, JNJ forecast full-year 2012 earnings to range from $5.05 to $5.10 per share, which straddles analysts' outlook of of $5.08 per share for the year.

Johnson & Johnson shares rose 69 cents, or +1%, in premarket trading Tuesday.

The Bottom Line
We have been recommending shares of Johnson & Johnson ( JNJ ) since Apr.27, when the stock was trading at $64.75. The company has a 3.56% dividend yield, based on last night's closing stock price of $68.60.

Johnson & Johnson ( JNJ ) is a "Recommended" dividend stock, holding a DARS™ Rating of 3.5 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Created by

This article appears in: Investing , Stocks

Referenced Stocks: JNJ

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by